Kontula K, Andersson L C, Paavonen T, Myllylä G, Teerenhovi L, Vuopio P
Int J Cancer. 1980 Aug;26(2):177-83. doi: 10.1002/ijc.2910260209.
We have established optimal conditions for the measurement of glucocorticoid receptors (GR) in human white cells using a whole-cell binding assay with [3H]dexamethasone as the ligand, and the subsequent determination of the GR content in normal human lymphocytes and in leukemic cells of patients with various forms of acute and chronic leukemia. A number of leukemia cell lines in continuous culture were also subjected to the GR assay, and the results were correlated with the sensitivity of these cell lines to glucocorticoid steroids in vitro. The GR content of normal human lymphocytes amounted to 4,850 +/- 1,340 (mean +/- SD) receptors/cell. The mean equilibrium dissociation constant (KD) of the interaction of [3H]dexamethasone with the GR was 1.2 x 10(-8) M. Steroidal compounds with a known glucocorticoid potency effectively competed for the binding, whereas steroids devoid of glucocorticoid activity (e.g. estradiol-17 beta and testosterone) were ineffective. The GR content of the blast cells obtained from eight patients suffering from acute leukemia and four patients with a blast crisis of chronic myelocytic leukemia was found to be highly variable (3,230-29,900 receptors/cell), while the lymphocytes of six patients with chronic lymphatic leukemia contained a rather stable GR content (2,930-5,120 receptors/cell), which was comparable with that of normal lymphocytes. GR was identified in all the 12 malignant continuous white cell lines studied. Large cells contained more GR than the smaller ones. There was no apparent correlation between the GR concentration and the sensitivity of the cells in vitro to glucocorticoids as judged by [3H]thymidine incorporation studies. Distribution of the surface markers in the leukemic cell lines did not relate to the GR concentration. We conclude that the presence of GR is probably a universal feature of the leukemic cells, and, from a clinical standpoint, probably does not alone imply steroid responsiveness.
我们已建立了使用以[3H]地塞米松为配体的全细胞结合测定法来测量人白细胞中糖皮质激素受体(GR)的最佳条件,并随后测定正常人淋巴细胞以及患有各种急性和慢性白血病患者的白血病细胞中的GR含量。还对多种连续培养的白血病细胞系进行了GR测定,并将结果与这些细胞系在体外对糖皮质激素的敏感性相关联。正常人淋巴细胞的GR含量为4,850±1,340(平均值±标准差)受体/细胞。[3H]地塞米松与GR相互作用的平均平衡解离常数(KD)为1.2×10^(-8) M。具有已知糖皮质激素效力的甾体化合物有效地竞争结合,而缺乏糖皮质激素活性的类固醇(例如雌二醇-17β和睾酮)则无效。发现从8例急性白血病患者和4例慢性粒细胞白血病急变期患者获得的原始细胞的GR含量变化很大(3,230 - 29,900受体/细胞),而6例慢性淋巴细胞白血病患者的淋巴细胞中GR含量相当稳定(2,930 - 5,120受体/细胞),与正常淋巴细胞的GR含量相当。在所研究的所有12种恶性连续白细胞系中均鉴定出了GR。大细胞比小细胞含有更多的GR。通过[3H]胸苷掺入研究判断,GR浓度与细胞在体外对糖皮质激素的敏感性之间没有明显相关性。白血病细胞系中表面标志物的分布与GR浓度无关。我们得出结论,GR的存在可能是白血病细胞的普遍特征,并且从临床角度来看,可能并不单独意味着对类固醇有反应性。